Skip to main content
. 2022 Apr 26;35(2):123–129. doi: 10.1097/WNN.0000000000000305

TABLE 1.

Demographic Information and Medical History

Demographic/Clinical History M (SD) With Delirium Without Delirium t P
Age 78.25 (10.73) 78.65 (11.01) 77.85 (10.63) –0.428 0.669
Gender n (%) χ 2 P
 Female/male 74/62 (54/46) 37/31 37/31 0.00 1.00
Ethnicity
 Caucasian/White 116 (85) 57 59 0.06 0.81
 Asian/Pacific Islander 10 (7) 5 5 0.00 1.00
 Hispanic/Latinx 5 (4) 3 2 0.00 1.00
 African American/Black 2 (1) 1 1 0.00 1.00
 Unknown/unavailable 3 (2) 2 1 0.00 1.00
Living situation
 Assisted/independent 64/72 (47/53) 19/49 45/23 18.45 <0.001***
Medical comorbidities 126 (93) 66 60 2.7 0.1
 Hypertension 92 (68) 45 47 0.03 0.855
 Cardiovascular disease 75 (55) 44 31 4.28 0.039*
 Diabetes 47 (35) 23 24 0.00 1.00
 Chronic lung disease 34 (25) 16 18 0.04 0.843
 Chronic kidney disease 34 (25) 18 16 0.04 0.843
 Obesity 30 (22) 15 15 0.00 1.00
 Cancer 29 (21) 15 14 0.00 1.00
 Obstructive sleep apnea 23 (17) 11 12 0.00 1.00
 Liver disease 11 (8) 4 7 0.40 0.529
Neurologic comorbidities 72 (53) 58 14 54.57 <0.001***
 Dementia 49 (36) 44 5 46.07 <0.001***
 Stroke 25 (18) 20 5 9.60 0.002**
 Brain tumor 5 (4) 4 1 0.83 0.366
 Parkinson’s disease 4 (3) 3 1 0.26 0.619
 Seizure disorder 3 (2) 3 0 1.37 0.244
 Multiple sclerosis 2 (1) 2 0 0.51 0.496
Psychiatric comorbidities 74 (54) 45 29 6.67 0.01*
 Depression 55 (40) 32 23 1.95 0.162
 Anxiety 30 (22) 16 14 0.04 0.836
 Insomnia 17 (13) 12 5 2.42 0.120
 Opioid use disorder 12 (9) 9 3 2.29 0.131
 Alcohol use disorder 8 (6) 5 3 0.13 0.718
 Bipolar disorder 8 (6) 6 2 1.20 0.274
 Schizophrenia 5 (4) 5 0 3.32 0.058
Other predisposing factors
 Prior delirium 42 (31) 33 9 17.36 <0.001***
 Deliriogenic medications 68 (50) 44 24 10.62 0.001**
 Baseline hearing impairment 17 (13) 11 6 1.08 0.300
 Baseline visual impairment 7 (5) 5 2 0.60 0.438
*

Significant at P < 0.05.

**

Significant at P < 0.01.

***

Significant at P < 0.001.